Lyme disease in central Europe

Citation
J. Hercogova et I. Brzonova, Lyme disease in central Europe, CURR OPIN I, 14(2), 2001, pp. 133-137
Citations number
42
Categorie Soggetti
Clinical Immunolgy & Infectious Disease
Journal title
CURRENT OPINION IN INFECTIOUS DISEASES
ISSN journal
09517375 → ACNP
Volume
14
Issue
2
Year of publication
2001
Pages
133 - 137
Database
ISI
SICI code
0951-7375(200104)14:2<133:LDICE>2.0.ZU;2-S
Abstract
Lyme borreliosis is a fascinating disease, the aetiopathology of which is n ot yet completely known. Different subspecies of Borrelia burgdorferi sensu late are responsible for the variable clinical course of the disease. Some new cutaneous (alopecia) and ocular (photophobia and retinal vasculitis) m anisfestations have been described and the largest prospective study on ery thema migrans during pregnancy was published during the last year. Optimal therapy of Lyme borreliosis is still lacking, but doxycycline, amoxicillin, penicillin, and ceftriaxone are recommended most frequently. Curr Opin Inf ect Dis 14:133-137. (C) 2001 Lippincott Williams & Wilkins.